Reporting recommendations for tumor marker prognostic studies (REMARK).

@article{McShane2005ReportingRF,
  title={Reporting recommendations for tumor marker prognostic studies (REMARK).},
  author={L. McShane and D. Altman and W. Sauerbrei and S. Taube and M. Gion and G. Clark},
  journal={Journal of the National Cancer Institute},
  year={2005},
  volume={97 16},
  pages={
          1180-4
        }
}
Despite years of research and hundreds of reports on tumor markers in oncology, the number of markers that have emerged as clinically useful is pitifully small. Often, initially reported studies of a marker show great promise, but subsequent studies on the same or related markers yield inconsistent conclusions or stand in direct contradiction to the promising results. It is imperative that we attempt to understand the reasons that multiple studies of the same marker lead to differing… Expand
Identification of clinically useful cancer prognostic factors: what are we missing?
Prognostic molecular markers in cancer – quo vadis?
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 44 REFERENCES
Evaluating Prognostic Factor Studies
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers.
...
1
2
3
4
5
...